Mortality predictors in patients with type 2 diabetes
PhD ceremony: Mr. G.W.D. Landman, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Mortality predictors in patients with type 2 diabetes
Promotor(s): prof. H.J.G. Bilo, prof. R.O.B. Gans
Faculty: Medical Sciences
This thesis deals with the relationship between specific risk factors and mortality in patients with type 2 diabetes mellitus (T2DM). The goals of the thesis were (1) to study factors which might be associated with total as well as cardiovascular mortality in a general and elderly group of patients with T2DM, and (2) to develop a risk calculator to calculate individual patient risk. All data were obtained from the ZODIAC cohort, a prospective observational study which was conducted in a primary health care setting.
Our studies show that classic risk factors for cardiovascular disease, including hypertension and hypercholesterolemia, have a different association in the elderly compared to younger patients. Besides the known beneficial effects of metformin on cardiovascular disease, we have shown that metformin may have a positive effect on cancer-related mortality. HRQOL and two SNPs appear to be associated with mortality, however in risk prediction they are of no additional value. Risk prediction for individual patients, as done with the UKPDS Risk Engine, has been insufficiently validated in the Dutch population and should not be used in the Netherlands. Renal dysfunction could play an important role in individual mortality risk prediction.
Last modified: | 13 March 2020 12.58 a.m. |
More news
-
29 November 2023
UMCG opent nieuwe faciliteit voor microbioomonderzoek 
Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...
-
28 November 2023
Science: more exciting than showbiz
Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...
-
13 November 2023
UMCG beantwoordt vragen patiënten met hulp van AI
Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...